Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 4.88108501 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.88108501 |
3 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.73480579 |
4 | protein carboxylation (GO:0018214) | 4.73480579 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 4.53159911 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.52895014 |
7 | L-phenylalanine metabolic process (GO:0006558) | 4.52895014 |
8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.52889463 |
9 | negative regulation of fibrinolysis (GO:0051918) | 4.46797454 |
10 | urea cycle (GO:0000050) | 4.40580842 |
11 | urea metabolic process (GO:0019627) | 4.40580842 |
12 | indolalkylamine catabolic process (GO:0046218) | 4.30755278 |
13 | tryptophan catabolic process (GO:0006569) | 4.30755278 |
14 | indole-containing compound catabolic process (GO:0042436) | 4.30755278 |
15 | kynurenine metabolic process (GO:0070189) | 4.22928755 |
16 | regulation of fibrinolysis (GO:0051917) | 4.22821398 |
17 | complement activation, alternative pathway (GO:0006957) | 4.20642121 |
18 | tryptophan metabolic process (GO:0006568) | 4.15417066 |
19 | bile acid biosynthetic process (GO:0006699) | 4.13258494 |
20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.12201294 |
21 | regulation of protein activation cascade (GO:2000257) | 4.10680977 |
22 | nitrogen cycle metabolic process (GO:0071941) | 3.93853958 |
23 | phospholipid efflux (GO:0033700) | 3.88372595 |
24 | regulation of complement activation (GO:0030449) | 3.85719962 |
25 | alpha-linolenic acid metabolic process (GO:0036109) | 3.79431073 |
26 | reverse cholesterol transport (GO:0043691) | 3.77026530 |
27 | fibrinolysis (GO:0042730) | 3.70729833 |
28 | regulation of triglyceride catabolic process (GO:0010896) | 3.60484247 |
29 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.60323171 |
30 | negative regulation of cholesterol transport (GO:0032375) | 3.58498727 |
31 | negative regulation of sterol transport (GO:0032372) | 3.58498727 |
32 | response to peptidoglycan (GO:0032494) | 3.53691743 |
33 | plasma lipoprotein particle clearance (GO:0034381) | 3.53146676 |
34 | sulfur amino acid catabolic process (GO:0000098) | 3.52255973 |
35 | glyoxylate metabolic process (GO:0046487) | 3.50855870 |
36 | regulation of cholesterol esterification (GO:0010872) | 3.48208554 |
37 | protein-lipid complex remodeling (GO:0034368) | 3.46518291 |
38 | macromolecular complex remodeling (GO:0034367) | 3.46518291 |
39 | plasma lipoprotein particle remodeling (GO:0034369) | 3.46518291 |
40 | cellular extravasation (GO:0045123) | 3.46308053 |
41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.46305050 |
42 | cysteine metabolic process (GO:0006534) | 3.46067427 |
43 | bile acid metabolic process (GO:0008206) | 3.45703367 |
44 | regulation of cholesterol homeostasis (GO:2000188) | 3.43146761 |
45 | cholesterol efflux (GO:0033344) | 3.35630364 |
46 | acute-phase response (GO:0006953) | 3.31077896 |
47 | tyrosine metabolic process (GO:0006570) | 3.30962210 |
48 | epoxygenase P450 pathway (GO:0019373) | 3.28017412 |
49 | homocysteine metabolic process (GO:0050667) | 3.26991858 |
50 | growth hormone receptor signaling pathway (GO:0060396) | 3.23479677 |
51 | cellular glucuronidation (GO:0052695) | 3.23073525 |
52 | plasma lipoprotein particle assembly (GO:0034377) | 3.22978348 |
53 | response to muramyl dipeptide (GO:0032495) | 3.22043478 |
54 | amino-acid betaine metabolic process (GO:0006577) | 3.16828074 |
55 | acylglycerol homeostasis (GO:0055090) | 3.15440953 |
56 | triglyceride homeostasis (GO:0070328) | 3.15440953 |
57 | positive regulation of lipid catabolic process (GO:0050996) | 3.15355605 |
58 | surfactant homeostasis (GO:0043129) | 3.15209170 |
59 | aromatic amino acid family metabolic process (GO:0009072) | 3.14218241 |
60 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.13273764 |
61 | negative regulation of lipase activity (GO:0060192) | 3.11172513 |
62 | negative regulation of interleukin-12 production (GO:0032695) | 3.05467605 |
63 | phospholipid homeostasis (GO:0055091) | 3.03777630 |
64 | protein localization to endosome (GO:0036010) | 3.01042418 |
65 | low-density lipoprotein particle remodeling (GO:0034374) | 3.00553397 |
66 | serine family amino acid catabolic process (GO:0009071) | 3.00161159 |
67 | indolalkylamine metabolic process (GO:0006586) | 2.99817970 |
68 | positive regulation of blood coagulation (GO:0030194) | 2.98846903 |
69 | positive regulation of hemostasis (GO:1900048) | 2.98846903 |
70 | bile acid and bile salt transport (GO:0015721) | 2.97911614 |
71 | hypotonic response (GO:0006971) | 2.96791547 |
72 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.96786215 |
73 | detection of molecule of bacterial origin (GO:0032490) | 2.96495174 |
74 | protein-lipid complex assembly (GO:0065005) | 2.93824000 |
75 | cell adhesion mediated by integrin (GO:0033627) | 2.93075695 |
76 | uronic acid metabolic process (GO:0006063) | 2.92576554 |
77 | glucuronate metabolic process (GO:0019585) | 2.92576554 |
78 | lipoprotein metabolic process (GO:0042157) | 2.92014242 |
79 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.91528958 |
80 | cellular biogenic amine catabolic process (GO:0042402) | 2.91353131 |
81 | amine catabolic process (GO:0009310) | 2.91353131 |
82 | detection of other organism (GO:0098543) | 2.91110796 |
83 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.90495642 |
84 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.90495642 |
85 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.88046915 |
86 | membrane raft organization (GO:0031579) | 2.86569275 |
87 | protein activation cascade (GO:0072376) | 2.85292569 |
88 | cholesterol homeostasis (GO:0042632) | 2.85000419 |
89 | complement activation (GO:0006956) | 2.82886443 |
90 | sterol homeostasis (GO:0055092) | 2.82632090 |
91 | positive regulation of coagulation (GO:0050820) | 2.82600852 |
92 | cellular response to ethanol (GO:0071361) | 2.82522942 |
93 | plasma lipoprotein particle organization (GO:0071827) | 2.82414812 |
94 | negative regulation of blood coagulation (GO:0030195) | 2.81516119 |
95 | negative regulation of hemostasis (GO:1900047) | 2.81516119 |
96 | embryonic process involved in female pregnancy (GO:0060136) | 2.81220214 |
97 | pinocytosis (GO:0006907) | 2.80382190 |
98 | opsonization (GO:0008228) | 2.80241326 |
99 | alpha-amino acid catabolic process (GO:1901606) | 2.78034140 |
100 | cholesterol transport (GO:0030301) | 2.75468183 |
101 | sterol transport (GO:0015918) | 2.75468183 |
102 | response to growth hormone (GO:0060416) | 2.75089077 |
103 | low-density lipoprotein particle clearance (GO:0034383) | 2.75079971 |
104 | benzene-containing compound metabolic process (GO:0042537) | 2.74212456 |
105 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.71958841 |
106 | regulation of plasminogen activation (GO:0010755) | 2.71339632 |
107 | complement activation, classical pathway (GO:0006958) | 2.70977716 |
108 | negative regulation of fatty acid transport (GO:2000192) | 2.70244069 |
109 | regulation of bile acid biosynthetic process (GO:0070857) | 2.69184232 |
110 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.68772516 |
111 | neutrophil activation involved in immune response (GO:0002283) | 2.68462159 |
112 | protein-lipid complex subunit organization (GO:0071825) | 2.68103483 |
113 | cellular response to growth hormone stimulus (GO:0071378) | 2.67738949 |
114 | T-helper 1 type immune response (GO:0042088) | 2.67631710 |
115 | arginine metabolic process (GO:0006525) | 2.67454238 |
116 | germinal center formation (GO:0002467) | 2.66768448 |
117 | blood coagulation, intrinsic pathway (GO:0007597) | 2.66634489 |
118 | detection of external biotic stimulus (GO:0098581) | 2.65918203 |
119 | negative regulation of coagulation (GO:0050819) | 2.65523258 |
120 | imidazole-containing compound metabolic process (GO:0052803) | 2.64903143 |
121 | drug catabolic process (GO:0042737) | 2.64769543 |
122 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.64479322 |
123 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.64149821 |
124 | macrophage activation involved in immune response (GO:0002281) | 2.63838009 |
125 | response to laminar fluid shear stress (GO:0034616) | 2.61060913 |
126 | wound healing, spreading of epidermal cells (GO:0035313) | 2.60471913 |
127 | skin morphogenesis (GO:0043589) | 2.58071776 |
128 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.57134035 |
129 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.56751375 |
130 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.56717798 |
131 | detection of biotic stimulus (GO:0009595) | 2.56465491 |
132 | detection of bacterium (GO:0016045) | 2.55276932 |
133 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.53654246 |
134 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.49867876 |
135 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.48597721 |
136 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.47365546 |
137 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.47055521 |
138 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.46240234 |
139 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.45480986 |
140 | negative regulation of cell killing (GO:0031342) | 2.45480986 |
141 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.43908536 |
142 | positive regulation of extracellular matrix organization (GO:1903055) | 2.43828884 |
143 | positive regulation by symbiont of host defense response (GO:0052509) | 2.42839352 |
144 | modulation by symbiont of host defense response (GO:0052031) | 2.42839352 |
145 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.42839352 |
146 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.42839352 |
147 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.42839352 |
148 | modulation by symbiont of host immune response (GO:0052553) | 2.42839352 |
149 | regulation of macrophage cytokine production (GO:0010935) | 2.41570020 |
150 | oligosaccharide catabolic process (GO:0009313) | 2.39240966 |
151 | positive regulation of leukocyte degranulation (GO:0043302) | 2.38391717 |
152 | negative regulation of interleukin-8 production (GO:0032717) | 2.36684259 |
153 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.34957822 |
154 | negative regulation of complement activation (GO:0045916) | 2.34419888 |
155 | hemidesmosome assembly (GO:0031581) | 2.32940745 |
156 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.32501907 |
157 | regulation of tolerance induction (GO:0002643) | 2.32452337 |
158 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.31199615 |
159 | negative regulation of protein activation cascade (GO:2000258) | 2.30213462 |
160 | mRNA transcription (GO:0009299) | 2.30014766 |
161 | negative regulation of interleukin-17 production (GO:0032700) | 2.29334620 |
162 | negative regulation of lipid storage (GO:0010888) | 2.29210144 |
163 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.28939721 |
164 | regulation of gamma-delta T cell activation (GO:0046643) | 2.28759409 |
165 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.27937312 |
166 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.26677678 |
167 | iron ion import (GO:0097286) | 2.26648521 |
168 | mature B cell differentiation involved in immune response (GO:0002313) | 2.25783226 |
169 | regulation of integrin activation (GO:0033623) | 2.24594050 |
170 | positive regulation of tolerance induction (GO:0002645) | 2.21483702 |
171 | chemical homeostasis within a tissue (GO:0048875) | 2.21243397 |
172 | regulation of vitamin metabolic process (GO:0030656) | 2.20147357 |
173 | peptide catabolic process (GO:0043171) | 2.17307751 |
174 | immunoglobulin mediated immune response (GO:0016064) | 2.16690574 |
175 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.15819162 |
176 | regulation of leukocyte degranulation (GO:0043300) | 2.15529313 |
177 | regulation of macrophage chemotaxis (GO:0010758) | 2.14979321 |
178 | macrophage activation (GO:0042116) | 2.13704127 |
179 | negative regulation of humoral immune response (GO:0002921) | 2.13511726 |
180 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.13165160 |
181 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.13091633 |
182 | positive regulation of type 2 immune response (GO:0002830) | 2.12878807 |
183 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.12556901 |
184 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.12039980 |
185 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.11680041 |
186 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.10190334 |
187 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.09237270 |
188 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.08819235 |
189 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.06620759 |
190 | establishment of endothelial barrier (GO:0061028) | 2.06487550 |
191 | regulation of mast cell degranulation (GO:0043304) | 2.06449388 |
192 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.06053205 |
193 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.05854190 |
194 | response to host (GO:0075136) | 2.05854190 |
195 | response to host defenses (GO:0052200) | 2.05854190 |
196 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.05464517 |
197 | regulation of necroptotic process (GO:0060544) | 2.05402150 |
198 | positive regulation of macrophage cytokine production (GO:0060907) | 2.05346654 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.88271943 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.29708155 |
3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.04732674 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.32092342 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.21942382 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.14209450 |
7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.51557570 |
8 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.35729220 |
9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.29323938 |
10 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.89882924 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.84215442 |
12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.73317009 |
13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65543265 |
14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.60262900 |
15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.55564324 |
16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.55098470 |
17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.49153956 |
18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.25819487 |
19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.24139573 |
20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.16147718 |
21 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.13164342 |
22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.93262249 |
23 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86891892 |
24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.79783442 |
25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75731044 |
26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.67634402 |
27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66797771 |
28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.64556364 |
29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.63537350 |
30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60464941 |
31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.59086717 |
32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56010313 |
33 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.52424316 |
34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.49822231 |
35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48931630 |
36 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.45225573 |
37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.43962307 |
38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43421937 |
39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40180182 |
40 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38337299 |
41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38205446 |
42 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37194008 |
43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.36601849 |
44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36245166 |
45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34264444 |
46 | CJUN_26792858_Chip-Seq_BT549_Human | 1.31472076 |
47 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.30030259 |
48 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.30030259 |
49 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.28678135 |
50 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.28678135 |
51 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.28074534 |
52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27459328 |
53 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27073589 |
54 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26991885 |
55 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.26635794 |
56 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.26046799 |
57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25354995 |
58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23981440 |
59 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.23203553 |
60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20593983 |
61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19462090 |
62 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18575579 |
63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17881814 |
64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16941025 |
65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13225067 |
66 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.12633208 |
67 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.12443229 |
68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12049734 |
69 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09258654 |
70 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09253521 |
71 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.08646179 |
72 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08603864 |
73 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08462871 |
74 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08435808 |
75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07673937 |
76 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07291493 |
77 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06410970 |
78 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06286166 |
79 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06100060 |
80 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.05651760 |
81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04852498 |
82 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.03161293 |
83 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02609843 |
84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00225399 |
85 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00104106 |
86 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98945095 |
87 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98291895 |
88 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98186618 |
89 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.96662028 |
90 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95605728 |
91 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95605728 |
92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95595152 |
93 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95108233 |
94 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.94724511 |
95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93354991 |
96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93197725 |
97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92235102 |
98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91266983 |
99 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.90898899 |
100 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90857701 |
101 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.90100689 |
102 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88460047 |
103 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.86044171 |
104 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85788902 |
105 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85493210 |
106 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.82913165 |
107 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.82831938 |
108 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.82578893 |
109 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.82487897 |
110 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.82014644 |
111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81326560 |
112 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81169075 |
113 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80582923 |
114 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80456348 |
115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.79771647 |
116 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.74703536 |
117 | MYB_26560356_Chip-Seq_TH2_Human | 0.73847767 |
118 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.72893303 |
119 | MAF_26560356_Chip-Seq_TH1_Human | 0.72300711 |
120 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.71572809 |
121 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70552993 |
122 | RXR_22108803_ChIP-Seq_LS180_Human | 0.70082014 |
123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69534035 |
124 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68899990 |
125 | MYB_26560356_Chip-Seq_TH1_Human | 0.68530912 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 5.96202935 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.82088075 |
3 | MP0005085_abnormal_gallbladder_physiolo | 3.96914143 |
4 | MP0005365_abnormal_bile_salt | 3.61876449 |
5 | MP0003705_abnormal_hypodermis_morpholog | 3.42841612 |
6 | * MP0008875_abnormal_xenobiotic_pharmacok | 3.09576658 |
7 | MP0003191_abnormal_cellular_cholesterol | 3.06011303 |
8 | MP0002138_abnormal_hepatobiliary_system | 2.68962513 |
9 | * MP0003252_abnormal_bile_duct | 2.67908742 |
10 | MP0009840_abnormal_foam_cell | 2.45972552 |
11 | MP0010329_abnormal_lipoprotein_level | 2.22349682 |
12 | MP0003724_increased_susceptibility_to | 2.20001419 |
13 | MP0010368_abnormal_lymphatic_system | 2.09560761 |
14 | MP0002877_abnormal_melanocyte_morpholog | 2.06007562 |
15 | MP0002254_reproductive_system_inflammat | 2.04032212 |
16 | MP0006054_spinal_hemorrhage | 1.88581904 |
17 | MP0001835_abnormal_antigen_presentation | 1.87221168 |
18 | MP0003091_abnormal_cell_migration | 1.87194525 |
19 | MP0003436_decreased_susceptibility_to | 1.84522700 |
20 | MP0008004_abnormal_stomach_pH | 1.83879088 |
21 | MP0003300_gastrointestinal_ulcer | 1.82907855 |
22 | MP0002998_abnormal_bone_remodeling | 1.82895927 |
23 | MP0000465_gastrointestinal_hemorrhage | 1.79445757 |
24 | MP0001958_emphysema | 1.79197124 |
25 | MP0003806_abnormal_nucleotide_metabolis | 1.73285434 |
26 | MP0010234_abnormal_vibrissa_follicle | 1.67461631 |
27 | * MP0000609_abnormal_liver_physiology | 1.65735631 |
28 | MP0001851_eye_inflammation | 1.64469413 |
29 | MP0001666_abnormal_nutrient_absorption | 1.63139132 |
30 | MP0005058_abnormal_lysosome_morphology | 1.62816355 |
31 | MP0003303_peritoneal_inflammation | 1.58725421 |
32 | * MP0003828_pulmonary_edema | 1.58062403 |
33 | MP0009785_altered_susceptibility_to | 1.56953525 |
34 | MP0002009_preneoplasia | 1.55029505 |
35 | * MP0009764_decreased_sensitivity_to | 1.53085116 |
36 | MP0004019_abnormal_vitamin_homeostasis | 1.52566850 |
37 | * MP0001853_heart_inflammation | 1.51378915 |
38 | MP0005083_abnormal_biliary_tract | 1.49764786 |
39 | MP0000685_abnormal_immune_system | 1.44424466 |
40 | MP0005275_abnormal_skin_tensile | 1.41984404 |
41 | MP0004947_skin_inflammation | 1.37497497 |
42 | MP0002796_impaired_skin_barrier | 1.35818961 |
43 | MP0002060_abnormal_skin_morphology | 1.34231714 |
44 | MP0003045_fibrosis | 1.32264538 |
45 | MP0005023_abnormal_wound_healing | 1.30136097 |
46 | MP0003763_abnormal_thymus_physiology | 1.27306688 |
47 | * MP0002420_abnormal_adaptive_immunity | 1.25465734 |
48 | * MP0001819_abnormal_immune_cell | 1.25027381 |
49 | MP0005332_abnormal_amino_acid | 1.23940591 |
50 | MP0002933_joint_inflammation | 1.23230364 |
51 | MP0001879_abnormal_lymphatic_vessel | 1.21648506 |
52 | MP0003950_abnormal_plasma_membrane | 1.20022811 |
53 | MP0003566_abnormal_cell_adhesion | 1.19499127 |
54 | MP0002118_abnormal_lipid_homeostasis | 1.18613221 |
55 | MP0004272_abnormal_basement_membrane | 1.18220121 |
56 | MP0008438_abnormal_cutaneous_collagen | 1.18074041 |
57 | * MP0003453_abnormal_keratinocyte_physiol | 1.17274564 |
58 | * MP0005025_abnormal_response_to | 1.17239429 |
59 | * MP0001790_abnormal_immune_system | 1.17059376 |
60 | * MP0005387_immune_system_phenotype | 1.17059376 |
61 | * MP0010155_abnormal_intestine_physiology | 1.16308616 |
62 | MP0003172_abnormal_lysosome_physiology | 1.16044981 |
63 | MP0000343_altered_response_to | 1.15097652 |
64 | MP0000858_altered_metastatic_potential | 1.13679041 |
65 | * MP0002419_abnormal_innate_immunity | 1.11627080 |
66 | MP0005409_darkened_coat_color | 1.11101041 |
67 | MP0002166_altered_tumor_susceptibility | 1.10946598 |
68 | MP0003195_calcinosis | 1.10675762 |
69 | MP0000569_abnormal_digit_pigmentation | 1.09473292 |
70 | MP0001533_abnormal_skeleton_physiology | 1.08904683 |
71 | MP0005451_abnormal_body_composition | 1.08836379 |
72 | MP0005390_skeleton_phenotype | 1.07779164 |
73 | MP0005000_abnormal_immune_tolerance | 1.07090945 |
74 | MP0004782_abnormal_surfactant_physiolog | 1.07065108 |
75 | MP0003656_abnormal_erythrocyte_physiolo | 1.05818744 |
76 | MP0001800_abnormal_humoral_immune | 1.05646137 |
77 | * MP0009763_increased_sensitivity_to | 1.05615836 |
78 | MP0002006_tumorigenesis | 1.05112154 |
79 | * MP0005319_abnormal_enzyme/_coenzyme | 1.03672932 |
80 | * MP0005165_increased_susceptibility_to | 1.03553714 |
81 | * MP0010352_gastrointestinal_tract_polyps | 1.02077133 |
82 | MP0004381_abnormal_hair_follicle | 1.01561475 |
83 | * MP0008469_abnormal_protein_level | 1.00903665 |
84 | MP0005397_hematopoietic_system_phenotyp | 0.98647511 |
85 | MP0001545_abnormal_hematopoietic_system | 0.98647511 |
86 | MP0003011_delayed_dark_adaptation | 0.98597970 |
87 | MP0004808_abnormal_hematopoietic_stem | 0.98271899 |
88 | MP0005248_abnormal_Harderian_gland | 0.98201279 |
89 | MP0005408_hypopigmentation | 0.97868674 |
90 | * MP0001216_abnormal_epidermal_layer | 0.96971928 |
91 | * MP0001845_abnormal_inflammatory_respons | 0.94888529 |
92 | MP0001881_abnormal_mammary_gland | 0.93746089 |
93 | MP0000604_amyloidosis | 0.93457618 |
94 | * MP0002405_respiratory_system_inflammati | 0.92134750 |
95 | MP0005464_abnormal_platelet_physiology | 0.91823236 |
96 | MP0005671_abnormal_response_to | 0.91323834 |
97 | * MP0002452_abnormal_antigen_presenting | 0.90371507 |
98 | MP0006082_CNS_inflammation | 0.90300993 |
99 | * MP0002723_abnormal_immune_serum | 0.89870492 |
100 | MP0000383_abnormal_hair_follicle | 0.89777034 |
101 | * MP0000716_abnormal_immune_system | 0.89190655 |
102 | * MP0002148_abnormal_hypersensitivity_rea | 0.89066514 |
103 | MP0009053_abnormal_anal_canal | 0.88626349 |
104 | MP0003279_aneurysm | 0.87415473 |
105 | MP0003795_abnormal_bone_structure | 0.86661056 |
106 | MP0002332_abnormal_exercise_endurance | 0.86154863 |
107 | * MP0000598_abnormal_liver_morphology | 0.85413372 |
108 | MP0002168_other_aberrant_phenotype | 0.85056569 |
109 | MP0001243_abnormal_dermal_layer | 0.84936071 |
110 | MP0003868_abnormal_feces_composition | 0.84065107 |
111 | MP0002896_abnormal_bone_mineralization | 0.83055232 |
112 | MP0009278_abnormal_bone_marrow | 0.81915691 |
113 | MP0009384_cardiac_valve_regurgitation | 0.81632244 |
114 | MP0005076_abnormal_cell_differentiation | 0.81027991 |
115 | MP0009643_abnormal_urine_homeostasis | 0.80557795 |
116 | MP0002398_abnormal_bone_marrow | 0.79463633 |
117 | * MP0000767_abnormal_smooth_muscle | 0.79049650 |
118 | MP0000249_abnormal_blood_vessel | 0.78012946 |
119 | MP0005166_decreased_susceptibility_to | 0.77255600 |
120 | MP0004510_myositis | 0.76991261 |
121 | * MP0000627_abnormal_mammary_gland | 0.76681333 |
122 | * MP0002133_abnormal_respiratory_system | 0.76435403 |
123 | * MP0005388_respiratory_system_phenotype | 0.76435403 |
124 | MP0000013_abnormal_adipose_tissue | 0.76218373 |
125 | MP0003448_altered_tumor_morphology | 0.75789276 |
126 | MP0001542_abnormal_bone_strength | 0.75491248 |
127 | MP0004264_abnormal_extraembryonic_tissu | 0.74795650 |
128 | MP0005595_abnormal_vascular_smooth | 0.74741295 |
129 | MP0002098_abnormal_vibrissa_morphology | 0.73945126 |
130 | MP0005167_abnormal_blood-brain_barrier | 0.73740010 |
131 | * MP0005584_abnormal_enzyme/coenzyme_acti | 0.73732298 |
132 | MP0000579_abnormal_nail_morphology | 0.73574657 |
133 | MP0005164_abnormal_response_to | 0.73467549 |
134 | MP0004883_abnormal_blood_vessel | 0.72812939 |
135 | MP0005501_abnormal_skin_physiology | 0.72700700 |
136 | MP0003075_altered_response_to | 0.72161507 |
137 | MP0009697_abnormal_copulation | 0.72078066 |
138 | MP0001764_abnormal_homeostasis | 0.72001815 |
139 | MP0010678_abnormal_skin_adnexa | 0.70745347 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.17551527 |
2 | Intrahepatic cholestasis (HP:0001406) | 5.32648403 |
3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.88881327 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 4.88568979 |
5 | Xanthomatosis (HP:0000991) | 4.76727369 |
6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.54107711 |
7 | Hypobetalipoproteinemia (HP:0003563) | 4.24534484 |
8 | Complement deficiency (HP:0004431) | 4.16268474 |
9 | Abnormality of the common coagulation pathway (HP:0010990) | 4.13250482 |
10 | Myocardial infarction (HP:0001658) | 4.10413184 |
11 | Joint hemorrhage (HP:0005261) | 3.99744997 |
12 | Epidermoid cyst (HP:0200040) | 3.74264704 |
13 | Hyperlipoproteinemia (HP:0010980) | 3.60879568 |
14 | Esophageal varix (HP:0002040) | 3.56584182 |
15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.50592178 |
16 | Hypercholesterolemia (HP:0003124) | 3.50253805 |
17 | Abnormality of complement system (HP:0005339) | 3.45511265 |
18 | Hypolipoproteinemia (HP:0010981) | 3.44179859 |
19 | Eczematoid dermatitis (HP:0000976) | 3.43737775 |
20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.43050252 |
21 | Spondylolisthesis (HP:0003302) | 3.40409673 |
22 | Hypoalphalipoproteinemia (HP:0003233) | 3.29110276 |
23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.14896563 |
24 | Peritonitis (HP:0002586) | 3.08260151 |
25 | Aortic dissection (HP:0002647) | 3.05433186 |
26 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.01858649 |
27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.01858649 |
28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.01858649 |
29 | Fat malabsorption (HP:0002630) | 2.99928995 |
30 | Abnormality of the intrinsic pathway (HP:0010989) | 2.87343151 |
31 | Aortic aneurysm (HP:0004942) | 2.86943273 |
32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.86081638 |
33 | Gingival bleeding (HP:0000225) | 2.82755745 |
34 | Spontaneous abortion (HP:0005268) | 2.78206676 |
35 | Premature rupture of membranes (HP:0001788) | 2.77246394 |
36 | Hepatocellular carcinoma (HP:0001402) | 2.70300520 |
37 | Arterial tortuosity (HP:0005116) | 2.68128364 |
38 | Dysostosis multiplex (HP:0000943) | 2.66419703 |
39 | Abnormality of macrophages (HP:0004311) | 2.65758138 |
40 | Conjugated hyperbilirubinemia (HP:0002908) | 2.65328131 |
41 | Hyperammonemia (HP:0001987) | 2.65022250 |
42 | Abnormality of methionine metabolism (HP:0010901) | 2.63715041 |
43 | Systemic lupus erythematosus (HP:0002725) | 2.58560261 |
44 | Vascular tortuosity (HP:0004948) | 2.52554521 |
45 | Subacute progressive viral hepatitis (HP:0006572) | 2.51414583 |
46 | Thrombophlebitis (HP:0004418) | 2.51029249 |
47 | Hypoglycemic coma (HP:0001325) | 2.49380469 |
48 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.48974127 |
49 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.45709329 |
50 | Gastrointestinal infarctions (HP:0005244) | 2.45669746 |
51 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.44702495 |
52 | Mitral stenosis (HP:0001718) | 2.44656172 |
53 | Vertebral compression fractures (HP:0002953) | 2.41999255 |
54 | Recurrent bacterial skin infections (HP:0005406) | 2.40529394 |
55 | Alopecia of scalp (HP:0002293) | 2.39286190 |
56 | Cerebral aneurysm (HP:0004944) | 2.37602787 |
57 | Cardiovascular calcification (HP:0011915) | 2.36724859 |
58 | Vascular calcification (HP:0004934) | 2.33513945 |
59 | Recurrent abscess formation (HP:0002722) | 2.31872849 |
60 | Mucopolysacchariduria (HP:0008155) | 2.29980136 |
61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.29980136 |
62 | Atrophic scars (HP:0001075) | 2.28701634 |
63 | Pulmonary embolism (HP:0002204) | 2.26621565 |
64 | Dilatation of the ascending aorta (HP:0005111) | 2.25809497 |
65 | Menorrhagia (HP:0000132) | 2.24031764 |
66 | Skin nodule (HP:0200036) | 2.23674770 |
67 | Hemorrhage of the eye (HP:0011885) | 2.23300633 |
68 | Hypochromic microcytic anemia (HP:0004840) | 2.22735301 |
69 | Nephritis (HP:0000123) | 2.22227998 |
70 | Polycythemia (HP:0001901) | 2.22174925 |
71 | Increased mean platelet volume (HP:0011877) | 2.21722732 |
72 | Absent frontal sinuses (HP:0002688) | 2.21568794 |
73 | Vacuolated lymphocytes (HP:0001922) | 2.20870155 |
74 | Pulmonary infiltrates (HP:0002113) | 2.20312681 |
75 | Optic neuritis (HP:0100653) | 2.19859744 |
76 | Retrobulbar optic neuritis (HP:0100654) | 2.19859744 |
77 | Spinal cord lesions (HP:0100561) | 2.18652441 |
78 | Syringomyelia (HP:0003396) | 2.18652441 |
79 | Steatorrhea (HP:0002570) | 2.17865201 |
80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16643127 |
81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16643127 |
82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16643127 |
83 | Camptodactyly of toe (HP:0001836) | 2.13534540 |
84 | Joint swelling (HP:0001386) | 2.12323260 |
85 | Periodontitis (HP:0000704) | 2.11360519 |
86 | Glomerulonephritis (HP:0000099) | 2.10996653 |
87 | Chorioretinal atrophy (HP:0000533) | 2.09687686 |
88 | Spontaneous hematomas (HP:0007420) | 2.08254305 |
89 | Interstitial pulmonary disease (HP:0006530) | 2.07602541 |
90 | Tetraparesis (HP:0002273) | 2.06896126 |
91 | Hydroxyprolinuria (HP:0003080) | 2.05367138 |
92 | Abnormality of proline metabolism (HP:0010907) | 2.05367138 |
93 | Abnormal platelet volume (HP:0011876) | 2.04793116 |
94 | Orchitis (HP:0100796) | 2.04516303 |
95 | Gingivitis (HP:0000230) | 2.02021883 |
96 | Cervical subluxation (HP:0003308) | 2.01924214 |
97 | Arterial thrombosis (HP:0004420) | 2.01783868 |
98 | Coarse hair (HP:0002208) | 2.00246668 |
99 | Stomatitis (HP:0010280) | 1.99867734 |
100 | Portal hypertension (HP:0001409) | 1.99239328 |
101 | Osteolytic defects of the hand bones (HP:0009699) | 1.98225672 |
102 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98225672 |
103 | Abnormality of nucleobase metabolism (HP:0010932) | 1.97042451 |
104 | Increased IgE level (HP:0003212) | 1.96549533 |
105 | Increased cerebral lipofuscin (HP:0011813) | 1.95205570 |
106 | Recurrent cutaneous fungal infections (HP:0011370) | 1.94934645 |
107 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.94934645 |
108 | Aneurysm (HP:0002617) | 1.94427666 |
109 | Pigmentary retinal degeneration (HP:0001146) | 1.93466240 |
110 | Wormian bones (HP:0002645) | 1.93289933 |
111 | Recurrent skin infections (HP:0001581) | 1.93289198 |
112 | Vasculitis (HP:0002633) | 1.92569683 |
113 | Autoimmune hemolytic anemia (HP:0001890) | 1.91458037 |
114 | Hematochezia (HP:0002573) | 1.90755098 |
115 | Right ventricular cardiomyopathy (HP:0011663) | 1.89041123 |
116 | Autoimmune thrombocytopenia (HP:0001973) | 1.88806077 |
117 | Ketosis (HP:0001946) | 1.88322061 |
118 | Spastic diplegia (HP:0001264) | 1.85704716 |
119 | Gangrene (HP:0100758) | 1.85462885 |
120 | Pancreatitis (HP:0001733) | 1.85210306 |
121 | Amyloidosis (HP:0011034) | 1.84430021 |
122 | Short nail (HP:0001799) | 1.83540885 |
123 | Persistence of primary teeth (HP:0006335) | 1.83243581 |
124 | Thick nail (HP:0001805) | 1.83002188 |
125 | Colitis (HP:0002583) | 1.82130777 |
126 | Keratoconjunctivitis sicca (HP:0001097) | 1.81876737 |
127 | Recurrent fungal infections (HP:0002841) | 1.81552263 |
128 | Hepatitis (HP:0012115) | 1.81121115 |
129 | Fatigue (HP:0012378) | 1.80341268 |
130 | Abnormality of the hepatic vasculature (HP:0006707) | 1.79627152 |
131 | Abnormality of iron homeostasis (HP:0011031) | 1.79291749 |
132 | Abnormality of T cell number (HP:0011839) | 1.79230318 |
133 | Hyperglycinemia (HP:0002154) | 1.79205208 |
134 | Viral hepatitis (HP:0006562) | 1.79162621 |
135 | Flat acetabular roof (HP:0003180) | 1.78396697 |
136 | Epistaxis (HP:0000421) | 1.78279921 |
137 | Hyperbilirubinemia (HP:0002904) | 1.77786724 |
138 | Protrusio acetabuli (HP:0003179) | 1.77431980 |
139 | Hypertriglyceridemia (HP:0002155) | 1.76406779 |
140 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.76048547 |
141 | Hyperglycinuria (HP:0003108) | 1.75942020 |
142 | Myositis (HP:0100614) | 1.74910216 |
143 | Delayed CNS myelination (HP:0002188) | 1.74807087 |
144 | Recurrent viral infections (HP:0004429) | 1.74461404 |
145 | Cellulitis (HP:0100658) | 1.74324408 |
146 | T lymphocytopenia (HP:0005403) | 1.73787070 |
147 | Abnormality of purine metabolism (HP:0004352) | 1.72709011 |
148 | Loss of speech (HP:0002371) | 1.72499157 |
149 | Mitral valve prolapse (HP:0001634) | 1.70933033 |
150 | Abnormality of the nasal septum (HP:0000419) | 1.69751105 |
151 | Urticaria (HP:0001025) | 1.68924295 |
152 | Follicular hyperkeratosis (HP:0007502) | 1.68802277 |
153 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.68463018 |
154 | Chest pain (HP:0100749) | 1.68332550 |
155 | Plantar hyperkeratosis (HP:0007556) | 1.68253376 |
156 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.68041298 |
157 | Hemoptysis (HP:0002105) | 1.67781122 |
158 | Mediastinal lymphadenopathy (HP:0100721) | 1.67748156 |
159 | Milia (HP:0001056) | 1.67693508 |
160 | Neurofibrillary tangles (HP:0002185) | 1.66758428 |
161 | Pustule (HP:0200039) | 1.65855305 |
162 | Distal lower limb amyotrophy (HP:0008944) | 1.65589975 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FGFR4 | 3.26199796 |
2 | ERN1 | 3.09508755 |
3 | MAP3K14 | 3.09420693 |
4 | SIK1 | 2.73579907 |
5 | EPHA3 | 2.68497672 |
6 | EPHB1 | 2.42907385 |
7 | PRPF4B | 2.39194461 |
8 | TGFBR2 | 2.30601874 |
9 | TXK | 2.28854768 |
10 | MST1R | 2.28384971 |
11 | TYK2 | 2.25428737 |
12 | LATS1 | 2.20696295 |
13 | FGFR3 | 2.04834370 |
14 | JAK3 | 2.00864432 |
15 | PTK6 | 1.98880798 |
16 | TBK1 | 1.96934063 |
17 | JAK1 | 1.92616907 |
18 | NEK9 | 1.86652002 |
19 | MAP4K1 | 1.83166665 |
20 | BLK | 1.80780781 |
21 | TAOK3 | 1.78390616 |
22 | STK10 | 1.69091003 |
23 | IKBKB | 1.56822402 |
24 | CHUK | 1.56080381 |
25 | MST4 | 1.54899612 |
26 | TIE1 | 1.53256032 |
27 | KIT | 1.48910375 |
28 | FRK | 1.45054412 |
29 | MAP3K3 | 1.41084532 |
30 | AKT3 | 1.40322500 |
31 | KDR | 1.38558582 |
32 | JAK2 | 1.37783818 |
33 | DDR2 | 1.36671979 |
34 | FER | 1.31468456 |
35 | MAP3K6 | 1.24317240 |
36 | ERBB4 | 1.23427853 |
37 | IKBKE | 1.20700843 |
38 | CDK6 | 1.19453106 |
39 | CDK12 | 1.19147053 |
40 | CSK | 1.18123241 |
41 | RIPK1 | 1.13877061 |
42 | ZAP70 | 1.13680803 |
43 | PBK | 1.11996295 |
44 | BCKDK | 1.10285320 |
45 | MAP2K3 | 1.08799200 |
46 | STK3 | 1.05957465 |
47 | TRPM7 | 1.05404928 |
48 | TGFBR1 | 1.03741958 |
49 | CDC42BPA | 1.02784207 |
50 | LRRK2 | 1.01723341 |
51 | TRIB3 | 1.01686647 |
52 | BMX | 1.00711486 |
53 | MAP3K10 | 1.00023575 |
54 | FES | 0.98340996 |
55 | IRAK4 | 0.94962976 |
56 | EPHB2 | 0.94847991 |
57 | MAP3K13 | 0.93144968 |
58 | EPHA2 | 0.91674979 |
59 | TTN | 0.90059088 |
60 | NLK | 0.88926668 |
61 | RIPK4 | 0.87733629 |
62 | MAP3K7 | 0.84603904 |
63 | STK24 | 0.84209861 |
64 | IRAK3 | 0.83801183 |
65 | PKN2 | 0.83364446 |
66 | MYLK | 0.80348757 |
67 | ITK | 0.79711733 |
68 | ERBB2 | 0.78655217 |
69 | FGFR2 | 0.77634309 |
70 | SGK3 | 0.75591025 |
71 | INSRR | 0.75280786 |
72 | SCYL2 | 0.75093832 |
73 | NUAK1 | 0.74106566 |
74 | FGFR1 | 0.74039767 |
75 | MATK | 0.73703272 |
76 | SYK | 0.73185878 |
77 | GRK7 | 0.73085648 |
78 | PAK4 | 0.72797660 |
79 | MELK | 0.71544300 |
80 | CSF1R | 0.71393796 |
81 | MET | 0.70749864 |
82 | RPS6KA4 | 0.69657292 |
83 | GSK3A | 0.68181125 |
84 | PTK2 | 0.67660532 |
85 | ABL1 | 0.66308849 |
86 | PDPK1 | 0.66007238 |
87 | MAP3K1 | 0.64626269 |
88 | WNK1 | 0.64613717 |
89 | PRKCQ | 0.63528557 |
90 | MAP3K2 | 0.63278198 |
91 | IGF1R | 0.63123712 |
92 | HCK | 0.63078443 |
93 | LMTK2 | 0.62965441 |
94 | PDGFRB | 0.61798741 |
95 | PIK3CG | 0.60565094 |
96 | CAMKK2 | 0.60037642 |
97 | TEC | 0.59634226 |
98 | MAPK11 | 0.58794335 |
99 | BTK | 0.58622067 |
100 | FLT3 | 0.57709408 |
101 | GRK6 | 0.56131697 |
102 | PAK2 | 0.55641710 |
103 | ABL2 | 0.54824178 |
104 | HIPK2 | 0.53578589 |
105 | LCK | 0.52989479 |
106 | RPS6KA2 | 0.52952056 |
107 | EEF2K | 0.52826212 |
108 | IRAK1 | 0.52630114 |
109 | GRK1 | 0.52627752 |
110 | PDK1 | 0.51811408 |
111 | IRAK2 | 0.51192132 |
112 | EGFR | 0.50069878 |
113 | RET | 0.49988409 |
114 | BRD4 | 0.49833411 |
115 | PIM1 | 0.49764766 |
116 | CAMK1D | 0.49037110 |
117 | LYN | 0.48878782 |
118 | SGK2 | 0.48641644 |
119 | MAP3K5 | 0.48547938 |
120 | INSR | 0.47747213 |
121 | MAPK7 | 0.47498465 |
122 | MAP3K11 | 0.47294946 |
123 | ICK | 0.46637855 |
124 | MTOR | 0.46434689 |
125 | BMPR2 | 0.45455736 |
126 | PRKAA2 | 0.41629432 |
127 | TAOK2 | 0.40795925 |
128 | MARK3 | 0.40293255 |
129 | MOS | 0.39095932 |
130 | PIK3CA | 0.38999433 |
131 | PDGFRA | 0.38575185 |
132 | SIK3 | 0.38299559 |
133 | ERBB3 | 0.38286665 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.25187225 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53901665 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21176783 |
4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.16707295 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.14445695 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.92912838 |
7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.56411635 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.26597179 |
9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16178714 |
10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.04702906 |
11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.03125780 |
12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96895321 |
13 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93842553 |
14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.90441436 |
15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87075209 |
16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.80954429 |
17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72943417 |
18 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71235101 |
19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.68589323 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.62031746 |
21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.60281384 |
22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.55936695 |
23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.55032953 |
24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.51884627 |
25 | Peroxisome_Homo sapiens_hsa04146 | 1.45865810 |
26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41965187 |
27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.35829429 |
28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35769277 |
29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.32815557 |
30 | Lysosome_Homo sapiens_hsa04142 | 1.32120889 |
31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30018691 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28767978 |
33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23114093 |
34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.20444321 |
35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.18778485 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.18270902 |
37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18168386 |
38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16159332 |
39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15250562 |
40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.14936629 |
41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14183446 |
42 | ABC transporters_Homo sapiens_hsa02010 | 1.11189171 |
43 | Platelet activation_Homo sapiens_hsa04611 | 1.10774143 |
44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07965006 |
45 | Phagosome_Homo sapiens_hsa04145 | 1.07635580 |
46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06218882 |
47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05037257 |
48 | Hepatitis B_Homo sapiens_hsa05161 | 1.03779162 |
49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03243469 |
50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02069844 |
51 | Leishmaniasis_Homo sapiens_hsa05140 | 1.01107679 |
52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00511429 |
53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99314124 |
54 | Malaria_Homo sapiens_hsa05144 | 0.95695245 |
55 | Salmonella infection_Homo sapiens_hsa05132 | 0.95109391 |
56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93127524 |
57 | Shigellosis_Homo sapiens_hsa05131 | 0.92682555 |
58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.91596313 |
59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91432110 |
60 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90294832 |
61 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.89864948 |
62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89014167 |
63 | Bladder cancer_Homo sapiens_hsa05219 | 0.86706488 |
64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86545678 |
65 | Apoptosis_Homo sapiens_hsa04210 | 0.86222508 |
66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85647263 |
67 | Allograft rejection_Homo sapiens_hsa05330 | 0.83886123 |
68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83648290 |
69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82592281 |
70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82094462 |
71 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.81985605 |
72 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80903206 |
73 | Lysine degradation_Homo sapiens_hsa00310 | 0.78787910 |
74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77903150 |
75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.77045415 |
76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76978287 |
77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75865123 |
78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75488811 |
79 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.72710642 |
80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72143317 |
81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71183991 |
82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71100512 |
83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68330017 |
84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68130487 |
85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66749498 |
86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66698031 |
87 | Amoebiasis_Homo sapiens_hsa05146 | 0.66485093 |
88 | Legionellosis_Homo sapiens_hsa05134 | 0.65928263 |
89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64603588 |
90 | Pertussis_Homo sapiens_hsa05133 | 0.64560640 |
91 | Insulin resistance_Homo sapiens_hsa04931 | 0.64310358 |
92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.63758752 |
93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62720286 |
94 | Measles_Homo sapiens_hsa05162 | 0.62601084 |
95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61626568 |
96 | Prostate cancer_Homo sapiens_hsa05215 | 0.61226733 |
97 | Asthma_Homo sapiens_hsa05310 | 0.60733506 |
98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60715916 |
99 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60677348 |
100 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60500296 |
101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59892640 |
102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59619035 |
103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59464947 |
104 | Adherens junction_Homo sapiens_hsa04520 | 0.58875583 |
105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58771623 |
106 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58272494 |
107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57298058 |
108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57149431 |
109 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56765736 |
110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56292323 |
111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56161434 |
112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54581018 |
113 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.54319180 |
114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54231386 |
115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53196900 |
116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52997239 |
117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52790363 |
118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52096085 |
119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51600481 |
120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51301117 |
121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50568494 |
122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49224828 |
123 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.49094216 |
124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48955375 |
125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.48214235 |
126 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47361075 |
127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47342098 |
128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46276244 |
129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46034203 |
130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46014446 |
131 | Endocytosis_Homo sapiens_hsa04144 | 0.44982381 |
132 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.44620582 |
133 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.44600342 |
134 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44252389 |
135 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43425354 |
136 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.43388995 |
137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43317462 |
138 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43276510 |
139 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42397309 |
140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42203906 |
141 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41901381 |
142 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40813728 |
143 | Prion diseases_Homo sapiens_hsa05020 | 0.40009531 |
144 | Tuberculosis_Homo sapiens_hsa05152 | 0.39687312 |
145 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.38706896 |
146 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38557617 |
147 | Hepatitis C_Homo sapiens_hsa05160 | 0.37930003 |
148 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37926855 |
149 | Influenza A_Homo sapiens_hsa05164 | 0.36142322 |
150 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35005106 |
151 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.34330511 |
152 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33903531 |
153 | Focal adhesion_Homo sapiens_hsa04510 | 0.33838836 |
154 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33625929 |
155 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.30804913 |
156 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30011152 |
157 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.29057215 |